☰

cached image

Stanley Fahn, M.D. - Publications

Affiliations: 
Neurology Columbia University, New York, NY 
Area:
movement disorders, parkinson disease
Tree Info Grants Similar researchers PubMed Report error

314 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Gupta DK, Viñuela A, Green PHR, Pitman MJ, Vonsattel JP, Fahn S. High-Frequency Palatal Tremor and Stimulus-Sensitive Leg Myoclonus with Degeneration of Inferior Olivary Nuclei in Celiac Disease. Movement Disorders Clinical Practice. 7: S93-S95. PMID 33015235 DOI: 10.1002/mdc3.13079  0.4
2020 Yu E, Rudakou U, Krohn L, Mufti K, Ruskey JA, Asayesh F, Estiar MA, Spiegelman D, Surface M, Fahn S, Waters CH, Greenbaum L, Espay AJ, Dauvilliers Y, Dupré N, et al. Analysis of Heterozygous PRKN Variants and Copy-Number Variations in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32970363 DOI: 10.1002/mds.28299  0.48
2020 Ouled Amar Bencheikh B, Senkevich K, Rudakou U, Yu E, Mufti K, Ruskey JA, Asayesh F, Laurent SB, Spiegelman D, Fahn S, Waters C, Monchi O, Dauvilliers Y, Espay AJ, Dupré N, et al. Variants in the Niemann-Pick type C gene NPC1 are not associated with Parkinson's disease. Neurobiology of Aging. PMID 32371106 DOI: 10.1016/j.neurobiolaging.2020.03.021  0.48
2020 Rudakou U, Ruskey JA, Krohn L, Laurent SB, Spiegelman D, Greenbaum L, Yahalom G, Desautels A, Montplaisir JY, Fahn S, Waters CH, Levy O, Kehoe CM, Narayan S, Dauvilliers Y, et al. Analysis of common and rare variants in late-onset Parkinson disease. Neurology. Genetics. 6: 385. PMID 32042909 DOI: 10.1212/NXG.0000000000000385  0.48
2019 Louis ED, Bares M, Benito-Leon J, Fahn S, Frucht SJ, Jankovic J, Ondo WG, Pal PK, Tan EK. Essential tremor-plus: a controversial new concept. The Lancet. Neurology. PMID 31767343 DOI: 10.1016/S1474-4422(19)30398-9  0.44
2019 Nwabuobi L, Tomishon D, Shneider NA, Fahn S, Vonsattel JP, Cortes E. Multiple System Atrophy With Predominant Striatonigral Degeneration and TAR DNA-Binding Protein of 43 kDa Pathology: An Unusual Variant of Multiple System Atrophy. Movement Disorders Clinical Practice. 6: 661-666. PMID 31745474 DOI: 10.1002/mdc3.12823  0.4
2019 Alcalay RN, Mallett V, Vanderperre B, Tavassoly O, Dauvilliers Y, Wu RYJ, Ruskey JA, Leblond CS, Ambalavanan A, Laurent SB, Spiegelman D, Dionne-Laporte A, Liong C, Levy OA, Fahn S, et al. SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30788890 DOI: 10.1002/mds.27642  0.52
2018 McRae C, Caspari J, Russell D, Ellgring H, Bezzant C, Greene P, Fahn S. Video Review of Baseline Performance on Global Ratings in a Double-Blind Placebo Surgery Trial. Movement Disorders Clinical Practice. 5: 597-602. PMID 30637279 DOI: 10.1002/mdc3.12666  0.44
2018 Merchant SH, Vial F, Leodori G, Fahn S, Pullman SL, Hallett M. A novel exaggerated "spino-bulbo-spinal like" reflex of lower brainstem origin. Parkinsonism & Related Disorders. PMID 30316728 DOI: 10.1016/j.parkreldis.2018.10.007  0.8
2018 Shah H, Liong C, Levy OA, Waters C, Fahn S, Marder K, Kang UJ, Wolf P, Oliva P, Zhang K, Alcalay RN, Gutierrez J. Association of Low Lysosomal Enzymes Activity With Brain Arterial Dilatation: A Pilot Study. Stroke. PMID 29986930 DOI: 10.1161/STROKEAHA.118.021964  0.4
2018 Ruskey JA, Greenbaum L, Roncière L, Alam A, Spiegelman D, Liong C, Levy OA, Waters C, Fahn S, Marder KS, Chung W, Yahalom G, Israeli-Korn S, Livneh V, Fay-Karmon T, et al. Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease. European Journal of Medical Genetics. PMID 29842932 DOI: 10.1016/j.ejmg.2018.05.005  0.48
2017 Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, ... ... Fahn S, et al. Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy. Movement Disorders : Official Journal of the Movement Disorder Society. 32: 1264-1310. PMID 28887905 DOI: 10.1002/mds.27115  0.8
2016 Sampson JB, Michaeli TH, Wright BA, Goldman JE, Vonsattel JP, Fahn S. Basal Ganglia Gliosis in a Case of Rapid-Onset Dystonia-Parkinsonism (DYT12) with a Novel Mutation in ATPase 1A3 (). Movement Disorders Clinical Practice. 3: 618-620. PMID 30838256 DOI: 10.1002/mdc3.12354  0.4
2016 Albanese A, Bhatia K, DeLong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Mink JW, Teller JK. "Complex" dystonia is not a category in the new 2013 consensus classification. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27612445 DOI: 10.1002/mds.26764  0.8
2016 Alcalay RN, Levy OA, Wolf P, Oliva P, Zhang XK, Waters CH, Fahn S, Kang U, Liong C, Ford B, Mazzoni P, Kuo S, Johnson A, Xiong L, Rouleau GA, et al. SCARB2 variants and glucocerebrosidase activity in Parkinson's disease. Npj Parkinson's Disease. 2. PMID 27110593 DOI: 10.1038/npjparkd.2016.4  0.52
2015 Xie T, Kang UJ, Kuo SH, Poulopoulos M, Greene P, Fahn S. Comparison of clinical features in pathologically confirmed PSP and MSA patients followed at a tertiary center. Npj Parkinson's Disease. 1: 15007. PMID 28725681 DOI: 10.1038/npjparkd.2015.7  0.44
2015 Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, ... ... Fahn S, et al. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. Jama Neurology. 1-9. PMID 26569098 DOI: 10.1001/jamaneurol.2015.2736  0.4
2015 McCarthy A, Lonergan R, Olszewska DA, O'Dowd S, Cummins G, Magennis B, Fallon EM, Pender N, Huey ED, Cosentino S, O'Rourke K, Kelly BD, O'Connell M, Delon I, Farrell M, ... ... Fahn S, et al. Closing the tau loop: the missing tau mutation. Brain : a Journal of Neurology. PMID 26297556 DOI: 10.1093/brain/awv234  0.84
2015 Virmani T, Moskowitz CB, Vonsattel JP, Fahn S. Clinicopathological characteristics of freezing of gait in autopsy-confirmed Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26234730 DOI: 10.1002/mds.26346  0.84
2015 Robakis D, Fahn S. Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease. Cns Drugs. 29: 433-41. PMID 26164425 DOI: 10.1007/s40263-015-0249-8  0.84
2015 Alcalay RN, Levy OA, Waters CC, Fahn S, Ford B, Kuo SH, Mazzoni P, Pauciulo MW, Nichols WC, Gan-Or Z, Rouleau GA, Chung WK, Wolf P, Oliva P, Keutzer J, et al. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations. Brain : a Journal of Neurology. PMID 26117366 DOI: 10.1093/brain/awv179  0.52
2015 Nomura Y, Fahn S. Masaya Segawa, MD, PhD, 1936-2014. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 883-5. PMID 26009805 DOI: 10.1002/mds.26257  0.84
2015 Clark LN, Chan R, Cheng R, Liu X, Park N, Parmalee N, Kisselev S, Cortes E, Torres PA, Pastores GM, Vonsattel JP, Alcalay R, Marder K, Honig LL, Fahn S, et al. Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body disease. Plos One. 10: e0125204. PMID 25933391 DOI: 10.1371/journal.pone.0125204  0.84
2015 Fahn S. Reply: Oleh Hornykiewicz's contribution to the l-dopa story. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1008-9. PMID 25880230 DOI: 10.1002/mds.26242  0.84
2015 Gan-Or Z, Alcalay RN, Bar-Shira A, Leblond CS, Postuma RB, Ben-Shachar S, Waters C, Johnson A, Levy O, Mirelman A, Gana-Weisz M, Dupré N, Montplaisir J, Giladi N, Fahn S, et al. Genetic markers of Restless Legs Syndrome in Parkinson disease. Parkinsonism & Related Disorders. 21: 582-5. PMID 25817513 DOI: 10.1016/j.parkreldis.2015.03.010  0.84
2015 Kestenbaum M, Fahn S. Safety of IPX066 , an extended release carbidopa-levodopa formulation, for the treatment of Parkinson's disease. Expert Opinion On Drug Safety. 14: 761-7. PMID 25697185 DOI: 10.1517/14740338.2015.1015986  0.84
2015 Fahn S. The medical treatment of Parkinson disease from James Parkinson to George Cotzias. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 4-18. PMID 25491387 DOI: 10.1002/mds.26102  0.84
2015 Sharp ME, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella C, Nance M, Bressman S, Scott WK, Tanner C, Waters C, Fahn S, et al. The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 278-83. PMID 25393808 DOI: 10.1002/mds.26065  0.84
2015 Alcalay RN, Mejia-Santana H, Mirelman A, Saunders-Pullman R, Raymond D, Palmese C, Caccappolo E, Ozelius L, Orr-Urtreger A, Clark L, Giladi N, Bressman S, Marder K, Tang MX, Santana HM, ... ... Fahn S, et al. Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease Parkinsonism and Related Disorders. 21: 106-110. DOI: 10.1016/j.parkreldis.2014.09.033  0.52
2014 Hall DA, Birch RC, Anheim M, Jønch AE, Pintado E, O'Keefe J, Trollor JN, Stebbins GT, Hagerman RJ, Fahn S, Berry-Kravis E, Leehey MA. Emerging topics in FXTAS. Journal of Neurodevelopmental Disorders. 6: 31. PMID 25642984 DOI: 10.1186/1866-1955-6-31  0.84
2014 Fahn S, Olanow CW. Reply to: psychogenic movement disorders: what's in a name? Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1699-701. PMID 25308926 DOI: 10.1002/mds.26042  0.84
2014 Simon KC, Eberly S, Gao X, Oakes D, Tanner CM, Shoulson I, Fahn S, Schwarzschild MA, Ascherio A. Mendelian randomization of serum urate and parkinson disease progression. Annals of Neurology. 76: 862-8. PMID 25257975 DOI: 10.1002/ana.24281  0.84
2014 Fahn S, Olanow CW. "Psychogenic movement disorders": they are what they are. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 853-6. PMID 24797587 DOI: 10.1002/mds.25899  0.84
2014 Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK. Reply: dystonia after severe head injuries. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 578-9. PMID 24590449 DOI: 10.1002/mds.25861  0.8
2014 Thaler A, Artzi M, Mirelman A, Jacob Y, Helmich RC, van Nuenen BF, Gurevich T, Orr-Urtreger A, Marder K, Bressman S, Bloem BR, Hendler T, Giladi N, Ben Bashat D. A voxel-based morphometry and diffusion tensor imaging analysis of asymptomatic Parkinson's disease-related G2019S LRRK2 mutation carriers. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 823-7. PMID 24482120 DOI: 10.1002/mds.25827  0.52
2014 Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella CL, Nance MA, Bressman SB, Scott WK, Tanner CM, Mickel SF, Waters CH, ... Fahn S, et al. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease. Jama Neurology. 71: 62-7. PMID 24190026 DOI: 10.1001/jamaneurol.2013.4498  0.52
2014 Pahwa R, Lyons KE, Hauser RA, Fahn S, Jankovic J, Pourcher E, Hsu A, O'Connell M, Kell S, Gupta S. Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease. Parkinsonism & Related Disorders. 20: 142-8. PMID 24055014 DOI: 10.1016/j.parkreldis.2013.08.017  0.84
2014 Fahn S, Goldman JS. Non-Parkinsonian Movement Disorders Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition. 869-890. DOI: 10.1016/B978-0-12-410529-4.00076-0  0.84
2013 Alcalay RN, Mirelman A, Saunders-Pullman R, Tang MX, Mejia Santana H, Raymond D, Roos E, Orbe-Reilly M, Gurevich T, Bar Shira A, Gana Weisz M, Yasinovsky K, Zalis M, Thaler A, Deik A, ... ... Fahn S, et al. Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1966-71. PMID 24243757 DOI: 10.1002/mds.25647  0.52
2013 Mirelman A, Heman T, Yasinovsky K, Thaler A, Gurevich T, Marder K, Bressman S, Bar-Shira A, Orr-Urtreger A, Giladi N, Hausdorff JM, Saunders-Pullman R, Shanker VL, Groves M, Palmese C, ... ... Fahn S, et al. Fall risk and gait in Parkinson's disease: The role of the LRRK2 G2019S mutation Movement Disorders. 28: 1683-1690. PMID 24123150 DOI: 10.1002/mds.25587  0.52
2013 Liu X, Cheng R, Ye X, Verbitsky M, Kisselev S, Mejia-Santana H, Louis E, Cote L, Andrews H, Waters C, Ford B, Fahn S, Marder K, Lee J, Clark L. Increased Rate of Sporadic and Recurrent Rare Genic Copy Number Variants in Parkinson's Disease Among Ashkenazi Jews. Molecular Genetics & Genomic Medicine. 1: 142-154. PMID 24073418 DOI: 10.1002/mgg3.18  0.52
2013 Klein C, Fahn S. Translation of Oppenheim's 1911 paper on dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 851-62. PMID 23893442 DOI: 10.1002/mds.25546  0.84
2013 Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK. Phenomenology and classification of dystonia: a consensus update. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 863-73. PMID 23649720 DOI: 10.1002/mds.25475  0.8
2012 Elble R, Comella C, Fahn S, Hallett M, Jankovic J, Juncos JL, Lewitt P, Lyons K, Ondo W, Pahwa R, Sethi K, Stover N, Tarsy D, Testa C, Tintner R, et al. Reliability of a new scale for essential tremor. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1567-9. PMID 23032792 DOI: 10.1002/mds.25162  0.84
2012 Thenganatt MA, Fahn S. Botulinum toxin for the treatment of movement disorders. Current Neurology and Neuroscience Reports. 12: 399-409. PMID 22661378 DOI: 10.1007/s11910-012-0286-3  0.84
2012 Poston KL, Tang CC, Eckert T, Dhawan V, Frucht S, Vonsattel JP, Fahn S, Eidelberg D. Network correlates of disease severity in multiple system atrophy. Neurology. 78: 1237-44. PMID 22491861 DOI: 10.1212/WNL.0b013e318250d7fd  0.4
2012 Alcalay RN, Caccappolo E, Mejia-Santana H, Tang M-, Rosado L, Orbe Reilly M, Ruiz D, Ross B, Verbitsky M, Kisselev S, Louis E, Comella C, Colcher A, Jennings D, Nance M, ... ... Fahn S, et al. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology. 78: 1434-40. PMID 22442429 DOI: 10.1212/WNL.0b013e318253d54b  0.52
2012 Poulopoulos M, Cortes E, Vonsattel JP, Fahn S, Waters C, Cote LJ, Moskowitz C, Honig LS, Clark LN, Marder KS, Alcalay RN. Clinical and pathological characteristics of LRRK2 G2019S patients with PD. Journal of Molecular Neuroscience : Mn. 47: 139-43. PMID 22194196 DOI: 10.1007/s12031-011-9696-y  0.4
2011 Srivastava A, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Caccappolo E, Comella C, Colcher A, Siderowf A, Jennings D, Nance M, Bressman S, Scott WK, Tanner C, Mickel S, ... ... Fahn S, et al. The relation between depression and parkin genotype: the CORE-PD study. Parkinsonism & Related Disorders. 17: 740-4. PMID 21856206 DOI: 10.1016/j.parkreldis.2011.07.008  0.52
2011 Liu X, Cheng R, Verbitsky M, Kisselev S, Browne A, Mejia-Sanatana H, Louis ED, Cote LJ, Andrews H, Waters C, Ford B, Frucht S, Fahn S, Marder K, Clark LN, et al. Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population. Bmc Medical Genetics. 12: 104. PMID 21812969 DOI: 10.1186/1471-2350-12-104  0.84
2011 Fahn S. Classification of movement disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 947-57. PMID 21626541 DOI: 10.1002/mds.23759  0.84
2011 Alcalay RN, Siderowf A, Ottman R, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Louis E, Ruiz D, Waters C, Fahn S, Cote L, Frucht S, Ford B, Orbe-Reilly M, et al. Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology. 76: 319-26. PMID 21205674 DOI: 10.1212/WNL.0b013e31820882aa  0.84
2011 Caccappolo E, Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, ... ... Fahn S, et al. Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study. Journal of the International Neuropsychological Society : Jins. 17: 91-100. PMID 21092386 DOI: 10.1017/S1355617710001190  0.84
2011 Donovan S, Lim C, Diaz N, Browner N, Rose P, Sudarsky LR, Tarsy D, Fahn S, Simon DK. Laserlight cues for gait freezing in Parkinson's disease: an open-label study. Parkinsonism & Related Disorders. 17: 240-5. PMID 20817535 DOI: 10.1016/j.parkreldis.2010.08.010  0.84
2010 Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Ross BM, Verbitsky M, Kisselev S, Louis ED, Comella C, Colcher A, Jennings D, Nance MA, Bressman SB, Scott WK, ... ... Fahn S, et al. Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Archives of Neurology. 67: 1116-22. PMID 20837857 DOI: 10.1001/archneurol.2010.194  0.84
2010 Schwid SR, Bausch J, Oakes D, Schuchter L, Tanner C, Forrest M, Lang AE, Shoulson I, Shoulson I, Hyson C, Oakes D, Flagg E, Rudolph A, Kieburtz K, ... ... Fahn S, et al. Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1801-8. PMID 20669311 DOI: 10.1002/mds.23006  0.84
2010 Gilbert RM, Fahn S, Mitsumoto H, Rowland LP. Parkinsonism and motor neuron diseases: twenty-seven patients with diverse overlap syndromes. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1868-75. PMID 20669307 DOI: 10.1002/mds.23200  0.84
2010 Goetz CG, Stebbins GT, Chmura TA, Fahn S, Poewe W, Tanner CM. Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS). Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1190-4. PMID 20629138 DOI: 10.1002/mds.23096  0.84
2010 Marder KS, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Comella CL, Colcher A, Siderowf AD, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, Andrews HF, ... ... Fahn S, et al. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Archives of Neurology. 67: 731-8. PMID 20558392 DOI: 10.1001/archneurol.2010.95  0.84
2010 Fahn S. Parkinson's disease: 10 years of progress, 1997-2007. Movement Disorders : Official Journal of the Movement Disorder Society. 25: S2-14. PMID 20187239 DOI: 10.1002/mds.22796  0.84
2010 Fahn S, Marder K, Côté L. Frontiers of science and clinical advances in quality of life in Parkinson's disease. Preface. Movement Disorders : Official Journal of the Movement Disorder Society. 25: S1. PMID 20187233 DOI: 10.1002/mds.23029  0.84
2010 Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Ross B, Verbitsky M, Kisselev S, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, ... ... Fahn S, et al. Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease. Journal of Clinical and Experimental Neuropsychology. 32: 775-9. PMID 20182943 DOI: 10.1080/13803390903521018  0.84
2010 Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, Gudesblatt M, Dhawan V, Lesser M, Vonsattel JP, Fahn S, Eidelberg D. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. The Lancet. Neurology. 9: 149-58. PMID 20061183 DOI: 10.1016/S1474-4422(10)70002-8  0.84
2010 Ma Y, Tang C, Chaly T, Greene P, Breeze R, Fahn S, Freed C, Dhawan V, Eidelberg D. Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 7-15. PMID 20008998 DOI: 10.2967/jnumed.109.066811  0.84
2010 schapira A, Lang A, Fahn S. PREFACE Blue Books of Neurology. 34: xxv. DOI: 10.1016/B978-1-4160-6641-5.00038-6  0.84
2009 Alcalay RN, Mejia-Santana H, Tang MX, Rosado L, Verbitsky M, Kisselev S, Ross BM, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner C, ... ... Fahn S, et al. Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. Archives of Neurology. 66: 1517-22. PMID 20008657 DOI: 10.1001/archneurol.2009.267  0.84
2009 Marras C, Lang AE, Eberly SW, Oakes D, Fahn S, Schwid SR, Hyson C, Shoulson I. A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 2370-8. PMID 19908310 DOI: 10.1002/mds.22828  0.84
2009 Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A, Chen CM, Clark LN, Condroyer C, De Marco EV, Dürr A, ... ... Fahn S, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. The New England Journal of Medicine. 361: 1651-61. PMID 19846850 DOI: 10.1056/NEJMoa0901281  0.84
2009 Ascherio A, LeWitt PA, Xu K, Eberly S, Watts A, Matson WR, Marras C, Kieburtz K, Rudolph A, Bogdanov MB, Schwid SR, Tennis M, Tanner CM, Beal MF, Lang AE, ... ... Fahn S, et al. Urate as a predictor of the rate of clinical decline in Parkinson disease. Archives of Neurology. 66: 1460-8. PMID 19822770 DOI: 10.1001/archneurol.2009.247  0.84
2009 Ravina B, Tanner C, Dieuliis D, Eberly S, Flagg E, Galpern WR, Fahn S, Goetz CG, Grate S, Kurlan R, Lang AE, Marek K, Kieburtz K, Oakes D, Elliott R, et al. A longitudinal program for biomarker development in Parkinson's disease: a feasibility study. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 2081-90. PMID 19691116 DOI: 10.1002/mds.22690  0.84
2009 Clark LN, Kartsaklis LA, Wolf Gilbert R, Dorado B, Ross BM, Kisselev S, Verbitsky M, Mejia-Santana H, Cote LJ, Andrews H, Vonsattel JP, Fahn S, Mayeux R, Honig LS, Marder K. Association of glucocerebrosidase mutations with dementia with lewy bodies. Archives of Neurology. 66: 578-83. PMID 19433657 DOI: 10.1001/archneurol.2009.54  0.84
2009 Holloway R, Marek K, Biglan K, Dick A, Fahn S, Julian-Baros E, Kamp C, Kieburtz K, Lang A, McDermott M, Seibyl J, Shinaman A, Shoulson I, Weiner W. Long-term effect of initiating Pramipexole vs Levodopa in early Parkinson disease Archives of Neurology. 66: 563-570. PMID 19433655 DOI: 10.1001/archneurol.2009.32  0.84
2009 Lang AE, Angel M, Bhatia K, Chen R, Fahn S, Hallett M, Schrag A, Thompson P. Myoclonus in complex regional pain syndrome. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 314-6; author reply . PMID 18973259 DOI: 10.1002/mds.22355  0.84
2008 Fahn S. How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both? Annals of Neurology. 64: S56-64. PMID 19127577 DOI: 10.1002/ana.21453  0.84
2008 Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 2129-70. PMID 19025984 DOI: 10.1002/mds.22340  0.84
2008 Fahn S. The history of dopamine and levodopa in the treatment of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 23: S497-508. PMID 18781671 DOI: 10.1002/mds.22028  0.84
2008 Schifitto G, Friedman JH, Oakes D, Shulman L, Comella CL, Marek K, Fahn S. Fatigue in levodopa-naive subjects with Parkinson disease. Neurology. 71: 481-5. PMID 18695158 DOI: 10.1212/01.wnl.0000324862.29733.69  0.84
2008 Frank S, Ondo W, Fahn S, Hunter C, Oakes D, Plumb S, Marshall F, Shoulson I, Eberly S, Walker F, Factor S, Hunt V, Shinaman A, Jankovic J. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease. Clinical Neuropharmacology. 31: 127-33. PMID 18520979 DOI: 10.1097/WNF.0b013e3180ca77ea  0.84
2008 Wang Y, Clark LN, Louis ED, Mejia-Santana H, Harris J, Cote LJ, Waters C, Andrews H, Ford B, Frucht S, Fahn S, Ottman R, Rabinowitz D, Marder K. Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method. Archives of Neurology. 65: 467-74. PMID 18413468 DOI: 10.1001/archneur.65.4.467  0.84
2008 Schwarzschild MA, Schwid SR, Marek K, Watts A, Lang AE, Oakes D, Shoulson I, Ascherio A, Hyson C, Gorbold E, Rudolph A, Kieburtz K, Fahn S, Gauger L, et al. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Archives of Neurology. 65: 716-23. PMID 18413464 DOI: 10.1001/archneur.2008.65.6.nct70003  0.84
2008 Goetz CG, Wuu J, McDermott MP, Adler CH, Fahn S, Freed CR, Hauser RA, Olanow WC, Shoulson I, Tandon PK, Leurgans S. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 690-9. PMID 18228568 DOI: 10.1002/mds.21894  0.84
2008 Fahn S. Historical perspectives on the current management of Parkinson's disease Focus On Parkinson's Disease. 20: 3-8.  0.84
2007 McClelland S, Vonsattel JP, Garcia RE, Amaya MD, Winfield LM, Pullman SL, Yu Q, Fahn S, Ford B, Goodman RR. Relationship of clinical efficacy to postmortem-determined anatomic subthalamic stimulation in Parkinson syndrome. Clinical Neuropathology. 26: 267-75. PMID 18232592  0.84
2007 Shoulson I, Schwid S, Hyson C, Oakes D, Gorbold E, Rudolph A, Shinaman A, Kamp C, Kieburtz K, Lang A, Fahn S, Gauger L, Goetz C, Marek K, Seibyl J. Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease Neurology. 69: 1480-1490. PMID 17881719 DOI: 10.1212/01.wnl.0000277648.63931.c0  0.84
2007 Clark LN, Ross BM, Wang Y, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology. 69: 1270-7. PMID 17875915 DOI: 10.1212/01.wnl.0000276989.17578.02  0.84
2007 Sanotsky Y, Lesyk R, Fedoryshyn L, Komnatska I, Matviyenko Y, Fahn S. Manganic encephalopathy due to "ephedrone" abuse. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1337-43. PMID 17566121 DOI: 10.1002/mds.21378  0.84
2007 Clark LN, Haamer E, Mejia-Santana H, Harris J, Lesage S, Durr A, Bs SJ, Hedrich K, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, et al. Construction and validation of a Parkinson's disease mutation genotyping array for the Parkin gene. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 932-7. PMID 17415800 DOI: 10.1002/mds.21419  0.84
2007 Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 68: 812-9. PMID 17353469 DOI: 10.1212/01.wnl.0000256715.13907.d3  0.84
2007 Nirenberg MJ, Libien J, Vonsattel JP, Fahn S. Multiple system atrophy in a patient with the spinocerebellar ataxia 3 gene mutation. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 251-4. PMID 17133518 DOI: 10.1002/mds.21231  0.84
2007 Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 41-7. PMID 17115387 DOI: 10.1002/mds.21198  0.84
2007 Marshall FJ, Fahn S, Clarence-Smith K. Reply from the authors [5] Neurology. 68: 797. DOI: 10.1212/01.wnl.0000259143.52138.5c  0.84
2006 Fahn S. Levodopa in the treatment of Parkinson's disease. Journal of Neural Transmission. Supplementum. 1-15. PMID 17447410  0.84
2006 Elble RJ, Watts R, Sethi K, Lyons K, Comella C, Fahn S, Hallett M, Jankovic J, Juncos J, Louis E, Ondo W, Pahwa R, Stern M, Tanner C, Tintner R. Report from a U.S. conference on essential tremor Movement Disorders. 21: 2052-2061. PMID 17078051 DOI: 10.1002/mds.21157  0.84
2006 Clark LN, Wang Y, Karlins E, Saito L, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology. 67: 1786-91. PMID 17050822 DOI: 10.1212/01.wnl.0000244345.49809.36  0.84
2006 Fahn S. A new look at levodopa based on the ELLDOPA study. Journal of Neural Transmission. Supplementum. 419-26. PMID 17017562  0.84
2006 deMarcaida JA, Schwid SR, White WB, Blindauer K, Fahn S, Kieburtz K, Stern M, Shoulson I. Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1716-21. PMID 16856145 DOI: 10.1002/mds.21048  0.84
2006 Elmer L, Schwid S, Eberly S, Goetz C, Fahn S, Kieburtz K, Oakes D, Blindauer K, Salzman P, Oren S, Prisco UL, Stern M, Shoulson I. Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms. Journal of the Neurological Sciences. 248: 78-83. PMID 16828804 DOI: 10.1016/j.jns.2006.05.014  0.84
2006 Clark LN, Afridi S, Karlins E, Wang Y, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K. Case-control study of the parkin gene in early-onset Parkinson disease. Archives of Neurology. 63: 548-52. PMID 16606767 DOI: 10.1001/archneur.63.4.548  0.84
2006 Biglan KM, Schwid S, Eberly S, Blindauer K, Fahn S, Goren T, Kieburtz K, Oakes D, Plumb S, Siderowf A, Stern M, Shoulson I. Rasagiline improves quality of life in patients with early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 616-23. PMID 16450340 DOI: 10.1002/mds.20764  0.84
2006 Portera-Cailliau C, Victor D, Frucht S, Fahn S. Movement disorders fellowship training program at Columbia University Medical Center in 2001-2002. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 479-85. PMID 16250019 DOI: 10.1002/mds.20740  0.84
2006 Olanow CW, Fahn S. Fetal nigral transplantation as a therapy for Parkinson's disease Restorative Therapies in Parkinson's Disease. 93-118. DOI: 10.1007/0-387-32823-2_6  0.84
2005 Williams DT, Ford B, Fahn S. Treatment issues in psychogenic-neuropsychiatric movement disorders. Advances in Neurology. 96: 350-63. PMID 16383231  0.84
2005 Fahn S. Does levodopa slow or hasten the rate of progression of Parkinson's disease? Journal of Neurology. 252: IV37-IV42. PMID 16222436 DOI: 10.1007/s00415-005-4008-5  0.84
2005 Marras C, Lang AE, Oakes D, McDermott MP, Kieburtz K, Shoulson I, Tanner CM, Fahn S. High-dosage vitamin E supplementation and all-cause mortality. Annals of Internal Medicine. 143: 152-3; author reply . PMID 16027463  0.84
2005 Blatt DH, Pryor WA, Krishnan K, Campbell S, Stone WL, Hemilä H, Lim WS, Liscic RM, Xiong C, Morris JC, Marras C, Lang AE, Oakes D, McDermott MP, Kieburtz K, ... ... Fahn S, et al. High-dosage vitamin E supplementation and all-cause mortality [1] (multiple letters) Annals of Internal Medicine. 143: 150-158. PMID 16027460 DOI: 10.7326/0003-4819-143-2-200507190-00018  0.84
2005 Walton-Hadlock JL, Fahn S, Keiburtz K, Tanner CM. Levodopa and the progression of Parkinson's disease [4] (multiple letters) New England Journal of Medicine. 352: 1386. PMID 15800240 DOI: 10.1056/NEJM200503313521324  0.84
2005 Levy G, Louis ED, Cote L, Perez M, Mejia-Santana H, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Marder K. Contribution of aging to the severity of different motor signs in Parkinson disease. Archives of Neurology. 62: 467-72. PMID 15767513 DOI: 10.1001/archneur.62.3.467  0.84
2005 Hirani N, Bayliff CC, McCormack DG, Frucht S, Agarwal P, Fahn S. Diagnosis and management of pergolide-induced fibrosis (multiple letters) [4] Movement Disorders. 20: 512-513. PMID 15739218 DOI: 10.1002/mds.20443  0.84
2005 Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, et al. The role of radiotracer imaging in Parkinson disease. Neurology. 64: 208-15. PMID 15668415 DOI: 10.1212/01.WNL.0000149403.14458.7F  0.84
2005 Clark LN, Nicolai A, Afridi S, Harris J, Mejia-Santana H, Strug L, Cote LJ, Louis ED, Andrews H, Waters C, Ford B, Frucht S, Fahn S, Mayeux R, Ottman R, et al. Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 100-3. PMID 15517591 DOI: 10.1002/mds.20320  0.84
2004 Fahn S, Sulzer D. Neurodegeneration and neuroprotection in Parkinson disease. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 1: 139-54. PMID 15717014 DOI: 10.1602/neurorx.1.1.139  0.84
2004 Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, Olanow CW, Tanner C, Marek K. Levodopa and the progression of Parkinson's disease. The New England Journal of Medicine. 351: 2498-508. PMID 15590952 DOI: 10.1056/NEJMoa033447  0.84
2004 Fahn S. ALS lessons learned from other neurological diseases. Parkinson's disease. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 5: 26-30. PMID 15512865 DOI: 10.1080/17434470410019852  0.84
2004 Margolis RL, Holmes SE, Rosenblatt A, Gourley L, O'Hearn E, Ross CA, Seltzer WK, Walker RH, Ashizawa T, Rasmussen A, Hayden M, Almqvist EW, Harris J, Fahn S, MacDonald ME, et al. Huntington's Disease-like 2 (HDL2) in North America and Japan. Annals of Neurology. 56: 670-4. PMID 15468075 DOI: 10.1002/ana.20248  0.84
2004 Ford B, Winfield L, Pullman SL, Frucht SJ, Du Y, Greene P, Cheringal JH, Yu Q, Cote LJ, Fahn S, McKhann GM, Goodman RR. Subthalamic nucleus stimulation in advanced Parkinson's disease: blinded assessments at one year follow up. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 1255-9. PMID 15314110 DOI: 10.1136/jnnp.2003.027557  0.84
2004 Gordon PH, Fahn S, Chin S, Golbe LI, Lynch T, Eidelberg D. Woman with a 26-year history of parkinsonism, supranuclear ophthalmoplegia, and loss of postural reflexes. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 950-61. PMID 15300663 DOI: 10.1002/mds.20139  0.84
2004 Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, et al. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Archives of Neurology. 61: 1044-53. PMID 15262734 DOI: 10.1001/archneur.61.7.1044  0.32
2004 Levy G, Louis ED, Mejia-Santana H, Côté L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R, Marder K. Lack of familial aggregation of Parkinson disease and Alzheimer disease. Archives of Neurology. 61: 1033-9. PMID 15262733 DOI: 10.1001/archneur.61.7.1033  0.84
2004 Clark LN, Afridi S, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Singleton A, Wavrant De-Vrieze F, Hardy J, Mayeux R, Fahn S, Waters C, Ford B, Frucht S, et al. Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 796-800. PMID 15254937 DOI: 10.1002/mds.20131  0.84
2004 Gordon PH, Yu Q, Qualls C, Winfield H, Dillon S, Greene PE, Fahn S, Breeze RE, Freed CR, Pullman SL. Reaction time and movement time after embryonic cell implantation in Parkinson disease. Archives of Neurology. 61: 858-61. PMID 15210522 DOI: 10.1001/archneur.61.6.858  0.84
2004 Agarwal P, Fahn S, Frucht SJ. Diagnosis and management of pergolide-induced fibrosis. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 699-704. PMID 15197712 DOI: 10.1002/mds.20200  0.84
2004 Freed CR, Breeze RE, Fahn S, Eidelberg D. Preoperative response to levodopa is the best predictor of transplant outcome. Annals of Neurology. 55: 896; author reply 89. PMID 15174028 DOI: 10.1002/ana.20085  0.84
2004 McRae C, Cherin E, Yamazaki TG, Diem G, Vo AH, Russell D, Ellgring JH, Fahn S, Greene P, Dillon S, Winfield H, Bjugstad KB, Freed CR. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Archives of General Psychiatry. 61: 412-20. PMID 15066900 DOI: 10.1001/archpsyc.61.4.412  0.84
2004 Fahn S. Deep-brain stimulation extends relief from Parkinson's. Electrodes deep in the brain continue relieving Parkinson's disease symptoms for five years. Health News (Waltham, Mass.). 10: 6-7. PMID 15002378  0.84
2004 Munhoz RP, Li JY, Kurtinecz M, Piboolnurak P, Constantino A, Fahn S, Lang AE. Evaluation of the pull test technique in assessing postural instability in Parkinson's disease. Neurology. 62: 125-7. PMID 14718714  0.84
2004 Furukawa Y, Kish SJ, Fahn S. Dopa-responsive dystonia due to mild tyrosine hydroxylase deficiency. Annals of Neurology. 55: 147-8. PMID 14705130 DOI: 10.1002/ana.10820  0.84
2003 Rosenberg RN, Pedley TA, Baringer JR, Fahn S, Lisak RP, Mayeux RP, Olson SF, Ringel SP, Rowland LP, Selzer ME. At jeopardy: the NIH as we know it. Neurorehabilitation and Neural Repair. 17: 203-5. PMID 14677215 DOI: 10.1177/0888439003259700  0.84
2003 Cohen O, Fahn S, Frucht SJ. Severe cervical dystonia in pathologically proven Parkinson's disease and dementia. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1381-2. PMID 14639686 DOI: 10.1002/mds.10604  0.84
2003 Louis ED, Levy G, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R, Marder K. Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD. Neurology. 61: 931-6. PMID 14557562 DOI: 10.1212/WNL.61.7.931  0.84
2003 Marder K, Levy G, Louis ED, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R. Familial aggregation of early- and late-onset Parkinson's disease. Annals of Neurology. 54: 507-13. PMID 14520664 DOI: 10.1002/ana.10711  0.84
2003 Rosenberg RN, Pedley TA, Baringer JR, Fahn S, Lisak RP, Mayeux RP, Olson SF, Ringel SP, Rowland LP, Selzer ME. At jeopardy: the NIH as we know it. Archives of Neurology. 60: 1191-2. PMID 12975281 DOI: 10.1001/archneur.60.9.1191  0.84
2003 Marder K, Levy G, Louis ED, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R. Accuracy of family history data on Parkinson's disease. Neurology. 61: 18-23. PMID 12847150 DOI: 10.1212/01.WNL.0000074784.35961.C0  0.84
2003 Fahn S. Description of Parkinson's disease as a clinical syndrome. Annals of the New York Academy of Sciences. 991: 1-14. PMID 12846969  0.84
2003 Trott CT, Fahn S, Greene P, Dillon S, Winfield H, Winfield L, Kao R, Eidelberg D, Freed CR, Breeze RE, Stern Y. Cognition following bilateral implants of embryonic dopamine neurons in PD: a double blind study. Neurology. 60: 1938-43. PMID 12821736 DOI: 10.1212/01.WNL.0000070181.28651.3B  0.84
2003 Lyons KE, Pahwa R, Comella CL, Eisa MS, Elble RJ, Fahn S, Jankovic J, Juncos JL, Koller WC, Ondo WG, Sethi KD, Stern MB, Tanner CM, Tintner R, Watts RL. Benefits and risks of pharmacological treatments for essential tremor. Drug Safety. 26: 461-81. PMID 12735785 DOI: 10.2165/00002018-200326070-00003  0.84
2003 McRae C, Cherin E, Diem G, Vo AH, Ellgring JH, Russell D, Fahn S, Freed C. Does personality change as a result of fetal tissue transplantation in the brain? Journal of Neurology. 250: 282-6. PMID 12638017 DOI: 10.1007/s00415-003-0986-3  0.84
2002 Bressman SB, Raymond D, Wendt K, Saunders-Pullman R, De Leon D, Fahn S, Ozelius L, Risch N. Diagnostic criteria for dystonia in DYT1 families. Neurology. 59: 1780-2. PMID 12473770 DOI: 10.1212/01.WNL.0000035630.12515.E0  0.84
2002 Gordon PH, Pullman SL, Louis ED, Frucht SJ, Fahn S. Mirtazapine in Parkinsonian tremor. Parkinsonism & Related Disorders. 9: 125-6. PMID 12473405 DOI: 10.1016/S1353-8020(02)00011-1  0.84
2002 Siderowf A, Stern M, Shoulson I, Kieburtz K, Oakes D, Day D, Shinaman A, Plumb S, Fahn S, Blindauer K, Lew M, Hurtig H, Lloyd M, Hauser R, Gauger L, et al. A controlled trial of rasagiline in early Parkinson disease: The tempo study Archives of Neurology. 59: 1937-1943. PMID 12470183 DOI: 10.1001/archneur.59.12.1937  0.84
2002 Chatterjee A, Fahn S. Methylphenidate treats apathy in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 14: 461-2. PMID 12426416 DOI: 10.1176/appi.neuropsych.14.4.461  0.84
2002 Ma Y, Feigin A, Dhawan V, Fukuda M, Shi Q, Greene P, Breeze R, Fahn S, Freed C, Eidelberg D. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Annals of Neurology. 52: 628-34. PMID 12402261 DOI: 10.1002/ana.10359  0.84
2002 Kock N, Müller B, Vieregge P, Pramstaller PP, Marder K, Abbruzzese G, Martinelli P, Lang AE, Jacobs H, Hagenah J, Harris J, Meija-Santana H, Fahn S, Hedrich K, Kann M, et al. Role of SCA2 mutations in early- and late-onset dopa-responsive parkinsonism. Annals of Neurology. 52: 257-8; author reply . PMID 12210804 DOI: 10.1002/ana.10270  0.4
2002 Louis ED, Levy G, Côte LJ, Mejia H, Fahn S, Marder K. Diagnosing Parkinson's disease using videotaped neurological examinations: validity and factors that contribute to incorrect diagnoses. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 513-7. PMID 12112199 DOI: 10.1002/mds.10119  0.44
2002 Hedrich K, Marder K, Harris J, Kann M, Lynch T, Meija-Santana H, Pramstaller PP, Schwinger E, Bressman SB, Fahn S, Klein C. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology. 58: 1239-46. PMID 11971093  0.48
2002 Frucht SJ, Leurgans SE, Hallett M, Fahn S. The Unified Myoclonus Rating Scale. Advances in Neurology. 89: 361-76. PMID 11968461  0.8
2002 Pedley TA, Swift TR, Miller A, Fahn S. Pharmaceutical industry support of the AAN Annual Meeting: policies and violation. Neurology. 58: 519-21. PMID 11865126  0.84
2002 Chuang C, Fahn S, Frucht SJ. The natural history and treatment of acquired hemidystonia: report of 33 cases and review of the literature. Journal of Neurology, Neurosurgery, and Psychiatry. 72: 59-67. PMID 11784827  0.4
2001 Lynch T, Sano M, Marder KS, Bell KL, Foster NL, Defendini RF, Sima AA, Keohane C, Nygaard TG, Fahn S, Mayeux R, Rowland LP, Wilhelmsen KC. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. 1994. Neurology. 57: S39-45. PMID 11775599  0.84
2001 Frucht SJ, Fahn S, Greene PE, O'Brien C, Gelb M, Truong DD, Welsh J, Factor S, Ford B. The natural history of embouchure dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 899-906. PMID 11746620 DOI: 10.1002/mds.1167  0.52
2001 Louis ED, Levy G, Côte LJ, Mejia H, Fahn S, Marder K. Clinical correlates of action tremor in Parkinson disease. Archives of Neurology. 58: 1630-4. PMID 11594921 DOI: 10.1001/ARCHNEUR.58.10.1630  0.44
2001 Frucht SJ, Louis ED, Chuang C, Fahn S. A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus. Neurology. 57: 1112-4. PMID 11571347 DOI: 10.1212/WNL.57.6.1112  0.44
2001 Nakamura T, Dhawan V, Chaly T, Fukuda M, Ma Y, Breeze R, Greene P, Fahn S, Freed C, Eidelberg D. Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease. Annals of Neurology. 50: 181-7. PMID 11506400 DOI: 10.1002/ana.1075  0.44
2001 Giladi N, McDermott MP, Fahn S, Przedborski S, Jankovic J, Stern M, Tanner C. Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology. 56: 1712-21. PMID 11425939 DOI: 10.1212/WNL.56.12.1712  0.84
2001 Louis ED, Winfield L, Fahn S, Ford B. Speech dysfluency exacerbated by levodopa in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 562-5. PMID 11391759 DOI: 10.1002/MDS.1081  0.52
2001 Bressman SB, Fahn S, Ozelius LJ, Kramer PL, Risch NJ. The DYT1 mutation and nonfamilial primary torsion dystonia. Archives of Neurology. 58: 681-2. PMID 11296011 DOI: 10.1001/ARCHNEUR.58.4.681  0.84
2001 Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. The New England Journal of Medicine. 344: 710-9. PMID 11236774 DOI: 10.1056/NEJM200103083441002  0.84
2001 Shoulson I, Penney J, McDermott M, Schwid S, Kayson E, Chase T, Fahn S, Greenamyre JT, Lang A, Siderowf A, Pearson N, Harrison M, Rost E, Colcher A, Lloyd M, et al. A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease. Neurology. 56: 455-62. PMID 11222787  0.52
2000 Thyagarajan D, Bressman S, Bruno C, Przedborski S, Shanske S, Lynch T, Fahn S, DiMauro S. A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy. Annals of Neurology. 48: 730-6. PMID 11079536 DOI: 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0  0.84
2000 Holloway R, Shoulson I, Kieburtz K, McDermott M, Tariot P, Kamp C, Day D, Shinaman A, Fahn S, Lang A, Marek K, Seibyl J, Weiner W, Welsh M, Pahwa R, et al. Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial Journal of the American Medical Association. 284: 1931-1938. PMID 11035889 DOI: 10.1001/jama.284.15.1931  0.84
2000 Klein C, Schilling K, Saunders-Pullman RJ, Garrels J, Breakefield XO, Brin MF, deLeon D, Doheny D, Fahn S, Fink JS, Forsgren L, Friedman J, Frucht S, Harris J, Holmgren G, et al. A major locus for myoclonus-dystonia maps to chromosome 7q in eight families. American Journal of Human Genetics. 67: 1314-9. PMID 11022010  0.84
2000 Frucht SJ, Greene PE, Fahn S. Sleep episodes in Parkinson's disease: a wake-up call. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 601-3. PMID 10928569  0.4
2000 Bressman SB, Sabatti C, Raymond D, de Leon D, Klein C, Kramer PL, Brin MF, Fahn S, Breakefield X, Ozelius LJ, Risch NJ. The DYT1 phenotype and guidelines for diagnostic testing. Neurology. 54: 1746-52. PMID 10802779  0.84
2000 Frucht S, Fahn S, Ford B. Focal task-specific dystonia induced by peripheral trauma. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 348-50. PMID 10752594  0.52
2000 Furukawa Y, Hornykiewicz O, Fahn S, Kish SJ. Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation. Neurology. 54: 1193-5. PMID 10720299  0.84
2000 Freed CR, Breeze RE, Fahn S. Placebo surgery in trials of therapy for Parkinson's disease. The New England Journal of Medicine. 342: 353-4; author reply . PMID 10660397 DOI: 10.1056/NEJM200002033420512  0.84
1999 Ozelius LJ, Page CE, Klein C, Hewett JW, Mineta M, Leung J, Shalish C, Bressman SB, de Leon D, Brin MF, Fahn S, Corey DP, Breakefield XO. The TOR1A (DYT1) gene family and its role in early onset torsion dystonia. Genomics. 62: 377-84. PMID 10644435 DOI: 10.1006/geno.1999.6039  0.84
1999 Agid Y, Ahlskog E, Albanese A, Calne D, Chase T, De Yebenes J, Factor S, Fahn S, Gershanik O, Goetz C, Koller W, Kurth M, Lang A, Lees A, Lewitt P, et al. Levodopa in the treatment of Parkinson's disease: a consensus meeting. Movement Disorders : Official Journal of the Movement Disorder Society. 14: 911-3. PMID 10584663 DOI: 10.1002/1531-8257(199911)14:6<911::AID-MDS1001>3.0.CO;2-H  0.84
1999 Frucht S, Fahn S, Ford B, Gelb M. A geste antagoniste device to treat jaw-closing dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 14: 883-6. PMID 10495062  0.52
1999 Frucht S, Rogers JD, Greene PE, Gordon MF, Fahn S. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology. 52: 1908-10. PMID 10371546  0.84
1999 Klein C, Brin MF, Kramer P, Sena-Esteves M, de Leon D, Doheny D, Bressman S, Fahn S, Breakefield XO, Ozelius LJ. Association of a missense change in the D2 dopamine receptor with myoclonus dystonia. Proceedings of the National Academy of Sciences of the United States of America. 96: 5173-6. PMID 10220438 DOI: 10.1073/pnas.96.9.5173  0.84
1999 Frucht S, Fahn S, Ford B. French horn embouchure dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 14: 171-3. PMID 9918368  0.52
1998 Lieberman A, Olanow CW, Sethi K, Swanson P, Waters CH, Fahn S, Hurtig H, Yahr M. A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease. Ropinirole Study Group. Neurology. 51: 1057-62. PMID 9781529 DOI: 10.1212/WNL.51.4.1057  0.84
1998 Ford B, Louis ED, Greene P, Fahn S. Outcome of selective ramisectomy for botulinum toxin resistant torticollis. Journal of Neurology, Neurosurgery, and Psychiatry. 65: 472-8. PMID 9771768 DOI: 10.1136/jnnp.65.4.472  0.52
1998 Fahn S, Clarence-Smith KE, Chase TN. Parkinson's disease: neurodegenerative mechanisms and neuroprotective interventions--report of a workshop. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 759-67. PMID 9756143 DOI: 10.1002/mds.870130502  0.84
1998 Wilhelmsen KC, Moskowitz CB, Weeks DE, Neystat M, Nygaard TG, Clark L, Dancoup M, Sobrevega EE, Rosales R, Gamez GL, Pacioles O, Perez M, Fahn S. Molecular genetic analysis of Lubag. Advances in Neurology. 78: 341-8. PMID 9750931  0.4
1998 Ford B, Greene PE, Louis ED, Bressman SB, Goodman RR, Brin MF, Sadiq S, Fahn S. Intrathecal baclofen in the treatment of dystonia. Advances in Neurology. 78: 199-210. PMID 9750916  0.52
1998 Bressman SB, de Leon D, Raymond D, Greene PE, Brin MF, Fahn S, Ozelius LJ, Breakefield XO, Kramer PL, Risch NJ. The role of the DYT1 gene in secondary dystonia. Advances in Neurology. 78: 107-15. PMID 9750907  0.84
1998 Ozelius LJ, Hewett JW, Page CE, Bressman SB, Kramer PL, Shalish C, de Leon D, Brin MF, Raymond D, Jacoby D, Penney J, Risch NJ, Fahn S, Gusella JF, Breakefield XO. The gene (DYT1) for early-onset torsion dystonia encodes a novel protein related to the Clp protease/heat shock family. Advances in Neurology. 78: 93-105. PMID 9750906  0.84
1998 Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, ... ... Fahn S, et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 393: 702-5. PMID 9641683 DOI: 10.1038/31508  0.84
1998 Vatassery GT, Fahn S, Kuskowski MA. Alpha tocopherol in CSF of subjects taking high-dose vitamin E in the DATATOP study. Parkinson Study Group. Neurology. 50: 1900-2. PMID 9633757  0.84
1998 Dalvi A, Fahn S, Ford B. Intrathecal baclofen in the treatment of dystonic storm. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 611-2. PMID 9613767 DOI: 10.1002/mds.870130344  0.84
1998 Dauer WT, Burke RE, Greene P, Fahn S. Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia. Brain : a Journal of Neurology. 121: 547-60. PMID 9577384 DOI: 10.1093/brain/121.4.547  0.84
1998 Fahn S, Chouinard S. Experience with tranylcypromine in early Parkinson's disease. Journal of Neural Transmission. Supplementum. 52: 49-61. PMID 9564607  0.84
1997 Chouinard S, Louis ED, Fahn S. Agreement among movement disorder specialists on the clinical diagnosis of essential tremor. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 973-6. PMID 9399223 DOI: 10.1002/mds.870120621  0.84
1997 Almasy L, Bressman SB, Raymond D, Kramer PL, Greene PE, Heiman GA, Ford B, Yount J, de Leon D, Chouinard S, Saunders-Pullman R, Brin MF, Kapoor RP, Jones AC, Shen H, ... Fahn S, et al. Idiopathic torsion dystonia linked to chromosome 8 in two Mennonite families. Annals of Neurology. 42: 670-3. PMID 9382482 DOI: 10.1002/ana.410420421  0.84
1997 Ozelius LJ, Hewett JW, Page CE, Bressman SB, Kramer PL, Shalish C, de Leon D, Brin MF, Raymond D, Corey DP, Fahn S, Risch NJ, Buckler AJ, Gusella JF, Breakefield XO. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nature Genetics. 17: 40-8. PMID 9288096 DOI: 10.1038/ng0997-40  0.84
1997 Lynch T, Fahn S, Louis ED, Odel JG. Oculofacial-skeletal myorhythmia in Whipple's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 625-6. PMID 9251096  0.48
1997 Lynch T, Odel J, Fredericks DN, Louis ED, Forman S, Rotterdam H, Fahn S, Relman DA. Polymerase chain reaction-based detection of Tropheryma whippelii in central nervous system Whipple's disease. Annals of Neurology. 42: 120-4. PMID 9225695 DOI: 10.1002/ana.410420120  0.84
1997 Bressman SB, de Leon D, Raymond D, Greene PE, Brin MF, Fahn S, Ozelius LJ, Breakefield XO, Kramer PL, Risch NJ. Secondary dystonia and the DYTI gene. Neurology. 48: 1571-7. PMID 9191768 DOI: 10.1212/WNL.48.6.1571  0.84
1997 Louis ED, Ottman R, Ford B, Pullman S, Martinez M, Fahn S, Hauser WA. The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology. 16: 124-33. PMID 9159767 DOI: 10.1159/000109681  0.84
1997 Ozelius LJ, Hewett J, Kramer P, Bressman SB, Shalish C, de Leon D, Rutter M, Risch N, Brin MF, Markova ED, Limborska SA, Ivanova-Smolenskaya IA, McCormick MK, Fahn S, Buckler AJ, et al. Fine localization of the torsion dystonia gene (DYT1) on human chromosome 9q34: YAC map and linkage disequilibrium. Genome Research. 7: 483-94. PMID 9149944 DOI: 10.1101/gr.7.5.483  0.48
1997 Kurlan R, Brin MF, Fahn S. Movement disorder in reflex sympathetic dystrophy: a case proven to be psychogenic by surveillance video monitoring. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 243-5. PMID 9087986 DOI: 10.1002/mds.870120218  0.48
1997 Louis ED, Klatka LA, Liu Y, Fahn S. Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease. Neurology. 48: 376-80. PMID 9040725 DOI: 10.1212/WNL.48.2.376  0.44
1997 Tan A, Salgado M, Fahn S. The characterization and outcome of stereotypical movements in nonautistic children. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 47-52. PMID 8990053 DOI: 10.1002/mds.870120109  0.84
1996 Ford B, Greene P, Louis ED, Petzinger G, Bressman SB, Goodman R, Brin MF, Sadiq S, Fahn S. Use of intrathecal baclofen in the treatment of patients with dystonia. Archives of Neurology. 53: 1241-6. PMID 8970452 DOI: 10.1001/archneur.1996.00550120049016  0.52
1996 Pullman SL, Greene P, Fahn S, Pedersen SF. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients. Archives of Neurology. 53: 617-24. PMID 8929169  0.84
1996 Bressman SB, Warner TT, Almasy L, Uitti RJ, Greene PE, Heiman GA, Raymond D, Ford B, de Leon D, Fahn S, Kramer PL, Risch NJ, Maraganore DM, Nygaard TG, Harding AE. Exclusion of the DYT1 locus in familial torticollis. Annals of Neurology. 40: 681-4. PMID 8871591 DOI: 10.1002/ana.410400421  0.84
1996 Louis ED, Lynch T, Kaufmann P, Fahn S, Odel J. Diagnostic guidelines in central nervous system Whipple's disease. Annals of Neurology. 40: 561-8. PMID 8871574 DOI: 10.1002/ana.410400404  0.48
1996 Ford B, Louis ED, Greene P, Fahn S. Oral and genital pain syndromes in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 421-6. PMID 8813222 DOI: 10.1002/mds.870110411  0.52
1996 Fahn S, Brin MF, Dwork AJ, Weiner WJ, Goetz CG, Rajput AH. Case 1, 1996: rapidly progressive parkinsonism, incontinence, impotency, and levodopa-induced moaning in a patient with multiple myeloma. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 298-310. PMID 8723148 DOI: 10.1002/mds.870110314  0.84
1996 Tan A, Salgado M, Fahn S. Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 214-6. PMID 8684394 DOI: 10.1002/mds.870110216  0.84
1996 Louis ED, Lynch T, Marder K, Fahn S. Reliability of patient completion of the historical section of the Unified Parkinson's Disease Rating Scale. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 185-92. PMID 8684390 DOI: 10.1002/mds.870110212  0.48
1996 Louis ED, Lynch T, Ford B, Greene P, Bressman SB, Fahn S. Delayed-onset cerebellar syndrome. Archives of Neurology. 53: 450-4. PMID 8624221 DOI: 10.1001/archneur.1996.00550050080027  0.52
1996 Louis ED, Fahn S. Pathologically diagnosed diffuse Lewy body disease and Parkinson's disease. Do the parkinsonian features differ? Advances in Neurology. 69: 311-4. PMID 8615144  0.44
1996 Pullman SL, Ford B, Elibol B, Uncini A, Su PC, Fahn S. Cutaneous electromyographic silent period findings in brachial dystonia. Neurology. 46: 503-8. PMID 8614522  0.84
1996 Penney JB, Oakes D, Shoulson I, Fahn S, Lang A, William Langston J, LeWitt P, Warren Olanow C, Tanner C, Kieburtz K. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa Annals of Neurology. 39: 37-45. PMID 8572664 DOI: 10.1002/ana.410390107  0.84
1995 Ford B, Fahn S, Pullman SL. Peripherally induced EMG silent periods. Normal physiology and disorders of motor control. Advances in Neurology. 67: 321-8. PMID 8848978  0.84
1995 Louis ED, Lynch T, Cargan AL, Fahn S. Generalized chorea in an infant with semilobar holoprosencephaly. Pediatric Neurology. 13: 355-7. PMID 8771177  0.48
1995 Eidelberg D, Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Przedborski S, Fahn S. The metabolic topography of idiopathic torsion dystonia. Brain : a Journal of Neurology. 118: 1473-84. PMID 8595478  0.84
1995 Stewart C, Winfield L, Hunt A, Bressman SB, Fahn S, Blitzer A, Brin MF. Speech dysfunction in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 562-5. PMID 8552106 DOI: 10.1002/mds.870100506  0.48
1995 Williams DT, Ford B, Fahn S. Phenomenology and psychopathology related to psychogenic movement disorders. Advances in Neurology. 65: 231-57. PMID 7872143  0.84
1995 McDermott MP, Jankovic J, Carter J, Fahn S, Gauthier S, Goetz CG, Golbe LI, Koller W, Lang AE, Olanow CW. Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group. Archives of Neurology. 52: 565-70. PMID 7763203 DOI: 10.1001/archneur.1995.00540300037010  0.84
1995 Louis ED, Goldman JE, Powers JM, Fahn S. Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 188-94. PMID 7753061 DOI: 10.1002/mds.870100209  0.84
1995 Greene P, Kang UJ, Fahn S. Spread of symptoms in idiopathic torsion dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 143-52. PMID 7753056 DOI: 10.1002/mds.870100204  0.44
1995 Przedborski S, Jackson-Lewis V, Fahn S. Antiparkinsonian therapies and brain mitochondrial complex I activity. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 312-7. PMID 7651449 DOI: 10.1002/mds.870100314  0.84
1995 Goetz CG, Stebbins GT, Chmura TA, Fahn S, Klawans HL, Marsden CD. Teaching tape for the motor section of the unified Parkinson's disease rating scale. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 263-6. PMID 7544438 DOI: 10.1002/mds.870100305  0.84
1995 Eidelberg D, Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Chaly T, Belakhlef A, Mandel F, Przedborski S, Fahn S. Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography. Neurology. 45: 1995-2004. PMID 7501148  0.84
1994 Bressman SB, Heiman GA, Nygaard TG, Ozelius LJ, Hunt AL, Brin MF, Gordon MF, Moskowitz CB, de Leon D, Burke RE. A study of idiopathic torsion dystonia in a non-Jewish family: evidence for genetic heterogeneity. Neurology. 44: 283-7. PMID 8309575 DOI: 10.1212/WNL.44.2.283  0.84
1994 Lynch T, Burke RE, Fahn S. Progress in psychiatry. The New England Journal of Medicine. 330: 285-6. PMID 8272093  0.52
1994 Greene P, Fahn S, Diamond B. Development of resistance to botulinum toxin type A in patients with torticollis. Movement Disorders : Official Journal of the Movement Disorder Society. 9: 213-7. PMID 8196686 DOI: 10.1002/mds.870090216  0.44
1994 Kieburtz K, McDermott M, Shoulson I, Oakes D, Fahn S, Lang A, Penney JB, Rodnitzky R, Shults C, Tanner C, Tetrud J, Brin M, Gordon M, LeWitt P, Bennett J, et al. A controlled trial of lazabemide (Ro 19-6327) in levodopa-treated Parkinson's disease Archives of Neurology. 51: 342-347. PMID 8155011 DOI: 10.1001/archneur.1994.00540160036006  0.84
1994 Olanow CW, Fahn S, Muenter M, Klawans H, Hurtig H, Stern M, Shoulson I, Kurlan R, Grimes JD, Jankovic J. A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 9: 40-7. PMID 8139604 DOI: 10.1002/mds.870090107  0.84
1994 Lew MF, Shindo M, Moskowitz CB, Wilhelmsen KC, Fahn S, Waters CH. Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome). Movement Disorders : Official Journal of the Movement Disorder Society. 9: 318-20. PMID 8041372 DOI: 10.1002/mds.870090307  0.84
1994 Ford B, Fahn S. Intrathecal baclofen. Neurology. 44: 1367-8. PMID 8035956  0.52
1994 Anderson RL, Blitzer A, Brin M, Carruthers A, Cornelia C, Consky E, Dubinsky R, Fahn S, Frueh BR, Hallett M, Jankovic J, Roman A, Kraft SP, Lang A, Ludlow C, et al. Training guidelines for the use of botulinum toxin for the treatment of neurologic disorders Neurology. 44: 2401-2403. PMID 7991136 DOI: 10.1212/wnl.44.12.2401  0.84
1994 Bressman SB, de Leon D, Kramer PL, Ozelius LJ, Brin MF, Greene PE, Fahn S, Breakefield XO, Risch NJ. Dystonia in Ashkenazi Jews: clinical characterization of a founder mutation. Annals of Neurology. 36: 771-7. PMID 7979224 DOI: 10.1002/ana.410360514  0.84
1994 Ford B, Greene P, Fahn S. Oral and genital tardive pain syndromes. Neurology. 44: 2115-9. PMID 7969969  0.52
1994 Fahn S, Mayeux R, Rowland LP. A new eponym: Wilhelmsen-Lynch disease. Neurology. 44: 1980. PMID 7936262 DOI: 10.1212/WNL.44.10.1980  0.84
1994 Lynch T, Sano M, Marder KS, Bell KL, Foster NL, Defendini RF, Sima AA, Keohane C, Nygaard TG, Fahn S. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology. 44: 1878-84. PMID 7936241 DOI: 10.1212/WNL.44.10.1878  0.84
1994 Pullman SL, Elibol B, Fahn S. Modulation of parkinsonian tremor by radial nerve palsy. Neurology. 44: 1861-4. PMID 7936237  0.84
1994 Bressman SB, Hunt AL, Heiman GA, Brin MF, Burke RE, Fahn S, Trugman JM, de Leon D, Kramer PL, Wilhelmsen KC. Exclusion of the DYT1 locus in a non-Jewish family with early-onset dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 9: 626-32. PMID 7845403 DOI: 10.1002/mds.870090608  0.84
1993 Eidelberg D, Takikawa S, Moeller JR, Dhawan V, Redington K, Chaly T, Robeson W, Dahl JR, Margouleff D, Fazzini E. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease. Annals of Neurology. 33: 518-27. PMID 8498828 DOI: 10.1002/ana.410330517  0.84
1993 Greene P, Cote L, Fahn S. Treatment of drug-induced psychosis in Parkinson's disease with clozapine. Advances in Neurology. 60: 703-6. PMID 8420214  0.84
1993 Singer C, Weiner WJ, Lange DJ, Brin MF, Greene P, Lovelace RE, Fahn S. Distant effects of locally injected botulinum toxin: A double-blind study of single fiber EMG changes [1] Muscle and Nerve. 16: 677. PMID 8389003 DOI: 10.1002/mus.880160615  0.84
1993 Waters CH, Takahashi H, Wilhelmsen KC, Shubin R, Snow BJ, Nygaard TG, Moskowitz CB, Fahn S, Calne DB. Phenotypic expression of X-linked dystonia-parkinsonism (lubag) in two women. Neurology. 43: 1555-8. PMID 8351010  0.4
1993 Pardo B, Mena MA, Fahn S, García de Yébenes J. Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line. Movement Disorders : Official Journal of the Movement Disorder Society. 8: 278-84. PMID 8341291 DOI: 10.1002/mds.870080305  0.84
1993 Nygaard TG, Wilhelmsen KC, Risch NJ, Brown DL, Trugman JM, Gilliam TC, Fahn S, Weeks DE. Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q. Nature Genetics. 5: 386-91. PMID 8298648 DOI: 10.1038/ng1293-386  0.84
1993 Gordon MF, Diaz-Olivo R, Hunt AL, Fahn S. Therapeutic trial of milacemide in patients with myoclonus and other intractable movement disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 8: 484-8. PMID 8232358 DOI: 10.1002/mds.870080412  0.84
1993 Giladi N, Sutton M, Lo B, Przedborski S, Fahn S, Cadet JL. Toxicity of the specific antimuscarinic agent methoctramine and other non-specific anticholinergic drugs in human neuroblastoma cell lines in vitro Toxicology in Vitro. 7: 595-603. DOI: 10.1016/0887-2333(93)90093-K  0.84
1992 Blitzer A, Brin MF, Stewart C, Aviv JE, Fahn S. Abductor laryngeal dystonia: a series treated with botulinum toxin. The Laryngoscope. 102: 163-7. PMID 1738288 DOI: 10.1288/00005537-199202000-00011  0.48
1992 Przedborski S, Kostic V, Jackson-Lewis V, Naini AB, Simonetti S, Fahn S, Carlson E, Epstein CJ, Cadet JL. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 12: 1658-67. PMID 1578260  0.84
1992 Mena MA, Pardo B, Casarejos MJ, Fahn S, García de Yébenes J. Neurotoxicity of levodopa on catecholamine-rich neurons. Movement Disorders : Official Journal of the Movement Disorder Society. 7: 23-31. PMID 1557063 DOI: 10.1002/mds.870070105  0.84
1992 Russman BS, Lang AE, Fahn S, Greene P, Grunnet ML. What is it? Case 1, 1992: progressive gait deterioration, peripheral neuropathy, optic atrophy, bradykinesia, and dystonia in a young girl. Movement Disorders : Official Journal of the Movement Disorder Society. 7: 373-9. PMID 1336568 DOI: 10.1002/mds.870070415  0.44
1991 Blitzer A, Brin MF, Fahn S. Botulinum toxin injections for lingual dystonia. The Laryngoscope. 101: 799. PMID 2062167 DOI: 10.1288/00005537-199107000-00024  0.48
1991 Chan J, Brin MF, Fahn S. Idiopathic cervical dystonia: clinical characteristics. Movement Disorders : Official Journal of the Movement Disorder Society. 6: 119-26. PMID 2057004 DOI: 10.1002/mds.870060206  0.48
1991 Saint Hilaire MH, Burke RE, Bressman SB, Brin MF, Fahn S. Delayed-onset dystonia due to perinatal or early childhood asphyxia. Neurology. 41: 216-22. PMID 1992364  0.52
1991 Lange DJ, Rubin M, Greene PE, Kang UJ, Moskowitz CB, Brin MF, Lovelace RE, Fahn S. Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Muscle & Nerve. 14: 672-5. PMID 1922173 DOI: 10.1002/mus.880140711  0.48
1991 Kwiatkowski DJ, Ozelius L, Kramer PL, Perman S, Schuback DE, Gusella JF, Fahn S, Breakefield XO. Torsion dystonia genes in two populations confined to a small region on chromosome 9q32-34. American Journal of Human Genetics. 49: 366-71. PMID 1867195  0.84
1991 Przedborski S, Levivier M, Kostic V, Jackson-Lewis V, Dollison A, Gash DM, Fahn S, Cadet JL. Sham transplantation protects against 6-hydroxydopamine-induced dopaminergic toxicity in rats: behavioral and morphological evidence. Brain Research. 550: 231-8. PMID 1832076 DOI: 10.1016/0006-8993(91)91323-S  0.84
1991 Giladi N, Greene P, Fahn S. [Botulinum toxin as a powerful new tool in the treatment of focal dystonia]. Harefuah. 121: 475-8. PMID 1786901  0.44
1991 Eidelberg D, Dhawan V, Moeller JR, Sidtis JJ, Ginos JZ, Strother SC, Cederbaum J, Greene P, Fahn S, Powers JM. The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography. Journal of Neurology, Neurosurgery, and Psychiatry. 54: 856-62. PMID 1744638 DOI: 10.1136/jnnp.54.10.856  0.84
1991 Pezzoli G, Zecchinelli A, Ricciardi S, Burke RE, Fahn S, Scarlato G, Carenzi A. Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian rats. Movement Disorders : Official Journal of the Movement Disorder Society. 6: 281-7. PMID 1684638 DOI: 10.1002/mds.870060403  0.52
1991 Schuback D, Kramer P, Ozelius L, Holmgren G, Forsgren L, Kyllerman M, Wahlström J, Craft CM, Nygaard T, Brin M, de Leon D, Bressman S, Moskowitz CB, Burke RE, Sanner G, ... ... Fahn S, et al. Dopamine beta-hydroxylase gene excluded in four subtypes of hereditary dystonia Human Genetics. 87: 311-316. PMID 1677923 DOI: 10.1007/BF00200910  0.84
1991 Wilhelmsen KC, Weeks DE, Nygaard TG, Moskowitz CB, Rosales RL, dela Paz DC, Sobrevega EE, Fahn S, Gilliam TC. Genetic mapping of "Lubag" (X-linked dystonia-parkinsonism) in a Filipino kindred to the pericentromeric region of the X chromosome. Annals of Neurology. 29: 124-31. PMID 1672807 DOI: 10.1002/ana.410290203  0.84
1990 Kramer PL, de Leon D, Ozelius L, Risch N, Bressman SB, Brin MF, Schuback DE, Burke RE, Kwiatkowski DJ, Shale H. Dystonia gene in Ashkenazi Jewish population is located on chromosome 9q32-34. Annals of Neurology. 27: 114-20. PMID 2317008 DOI: 10.1002/ana.410270203  0.84
1990 Risch NJ, Bressman SB, deLeon D, Brin MF, Burke RE, Greene PE, Shale H, Claus EB, Cupples LA, Fahn S. Segregation analysis of idiopathic torsion dystonia in Ashkenazi Jews suggests autosomal dominant inheritance. American Journal of Human Genetics. 46: 533-8. PMID 2309703  0.52
1990 Fahn S, Burke R, Stern Y. Antimuscarinic drugs in the treatment of movement disorders. Progress in Brain Research. 84: 389-97. PMID 2267310  0.48
1990 Greene PE, Fahn S, Lang AE, Watts RL, Eidelberg D, Powers JM. What is it? Case 1, 1990: progressive unilateral rigidity, bradykinesia, tremulousness, and apraxia, leading to fixed postural deformity of the involved limb. Movement Disorders : Official Journal of the Movement Disorder Society. 5: 341-51. PMID 2259362 DOI: 10.1002/mds.870050420  0.84
1990 Giladi N, Burke RE, Kostic V, Przedborski S, Gordon M, Hunt A, Fahn S. Hemiparkinsonism-hemiatrophy syndrome: clinical and neuroradiologic features. Neurology. 40: 1731-4. PMID 2234429 DOI: 10.1212/WNL.40.11.1731  0.52
1990 Park DH, Kang UJ, Moskowitz CB, Burke RE, Joh TH, Fahn S. Dopamine beta-hydroxylase activity in cerebrospinal fluid of idiopathic torsion dystonia. Neurology. 40: 1626-8. PMID 2215959 DOI: 10.1212/WNL.40.10.1626  0.84
1990 Greene P, Kang U, Fahn S, Brin M, Moskowitz C, Flaster E. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology. 40: 1213-8. PMID 2199847 DOI: 10.1212/WNL.40.8.1213  0.44
1990 Eidelberg D, Moeller JR, Dhawan V, Sidtis JJ, Ginos JZ, Strother SC, Cedarbaum J, Greene P, Fahn S, Rottenberg DA. The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies. Movement Disorders : Official Journal of the Movement Disorder Society. 5: 203-13. PMID 2117706 DOI: 10.1002/mds.870050304  0.84
1989 Bressman SB, de Leon D, Brin MF, Risch N, Burke RE, Greene PE, Shale H, Fahn S. Idiopathic dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance. Annals of Neurology. 26: 612-20. PMID 2817837 DOI: 10.1002/ana.410260505  0.52
1989 Truong DD, Diamond B, Pezzoli G, Mena MA, Fahn S. Monoamine oxidase inhibitory properties of milacemide in rats. Life Sciences. 44: 1059-66. PMID 2784529 DOI: 10.1016/0024-3205(89)90558-4  0.84
1989 Truong DD, Galloway MP, Pezzoli G, Jamrozik Z, Fahn S. Milacemide increases 5-hydroxytryptamine and dopamine levels in rat brain--possible mechanisms of milacemide antimyoclonic property in the p,p'-DDT-induced myoclonus. Pharmacology, Biochemistry, and Behavior. 32: 993-1001. PMID 2572009 DOI: 10.1016/0091-3057(89)90072-5  0.84
1989 Burke RE, Kang UJ, Jankovic J, Miller LG, Fahn S. Tardive akathisia: an analysis of clinical features and response to open therapeutic trials. Movement Disorders : Official Journal of the Movement Disorder Society. 4: 157-75. PMID 2567492 DOI: 10.1002/mds.870040208  0.52
1989 Mena MA, Garcia de Yebenes J, Dwork A, Fahn S, Latov N, Herbert J, Flaster E, Slonim D. Biochemical properties of monoamine-rich human neuroblastoma cells. Brain Research. 486: 286-96. PMID 2567196 DOI: 10.1016/0006-8993(89)90514-3  0.84
1989 Shoulson I, Fahn S, Oakes D, Odoroff C, Lang A, Langston JW, LeWitt P, Olanow W, Penney JB, Tanner C, Koller W, Rodnitzky R, Fink JS, Growdon JH, Paulson G, et al. Effect of deprenyl on the progression of disability in early Parkinson's disease New England Journal of Medicine. 321: 1364-1371. PMID 2509910 DOI: 10.1056/nejm198911163212004  0.84
1988 Mayeux R, Stern Y, Rosenstein R, Marder K, Hauser A, Cote L, Fahn S. An estimate of the prevalence of dementia in idiopathic Parkinson's disease. Archives of Neurology. 45: 260-2. PMID 3341950 DOI: 10.1001/archneur.1988.00520270034017  0.84
1988 de Yebenes JG, Fahn S, Jackson-Lewis V, Jorge P, Mena MA, Reiriz J. Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease Journal of Neural Transmission, Supplement. 27: 141-160. PMID 3165432 DOI: 10.1007/978-3-7091-8954-2_13  0.84
1988 de Yebenes JG, Brin MF, Mena MA, De Felipe C, del Rio RM, Bazan E, Martinez A, Fahn S, Del Rio J, Vazquez A. Neurochemical findings in neuroacanthocytosis. Movement Disorders : Official Journal of the Movement Disorder Society. 3: 300-12. PMID 2905427 DOI: 10.1002/mds.870030404  0.84
1987 Kramer PL, Ozelius L, Gusella JF, Fahn S, Kidd KK, Breakefield XO. Exclusion of autosomal dominant dystonia gene from large regions of chromosomes 11p, 13q, and 21q by multi-point linkage analysis. Genetic Epidemiology. 4: 377-86. PMID 3692135 DOI: 10.1002/gepi.1370040506  0.84
1987 de Yebenes JG, Fahn S, Jackson-Lewis V, Mena MA. The effect of intracerebroventricular infusion of (+)-4-propyl-9-hydroxynapthoxacine (PHNO) through a totally implanted drug delivery system in rats with dopamine deficiency Movement Disorders : Official Journal of the Movement Disorder Society. 2: 291-299. PMID 2904650 DOI: 10.1002/MDS.870020406  0.84
1986 Hassan MN, Reches A, Kuhn C, Higgins D, Fahn S. Pharmacologic evaluation of dopaminergic receptor blockade by metoclopramide Clinical Neuropharmacology. 9: 71-78. PMID 3829008 DOI: 10.1097/00002826-198602000-00008  0.36
1986 Burke RE, Fahn S, Marsden CD. Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology. 36: 160-4. PMID 3511401 DOI: 10.1212/WNL.36.2.160  0.52
1986 Burke RE, Brin MF, Fahn S, Bressman SB, Moskowitz C. Analysis of the clinical course of non-Jewish, autosomal dominant torsion dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 1: 163-78. PMID 3504242 DOI: 10.1002/mds.870010302  0.52
1986 Shale H, Fahn S, Mayeux R. Tics in a patient with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 1: 79-83. PMID 3504234 DOI: 10.1002/mds.870010111  0.84
1986 Hassan MN, Higgins D, Traub M, Fahn S. Chronic treatment with bromocriptine induces behavioral supersensitivity in rats Life Sciences. 39: 513-518. PMID 3090394 DOI: 10.1016/0024-3205(86)90507-2  0.84
1986 Mayeux R, Stern Y, Herman A, Greenbaum L, Fahn S. Correlates of early disability in Huntington's disease. Annals of Neurology. 20: 727-31. PMID 2949692 DOI: 10.1002/ana.410200613  0.84
1986 Kang UJ, Burke RE, Fahn S. Natural history and treatment of tardive dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 1: 193-208. PMID 2904118 DOI: 10.1002/mds.870010305  0.52
1986 Walters A, Hening W, Chokroverty S, Fahn S. Opioid responsiveness in patients with neuroleptic-induced akathisia. Movement Disorders : Official Journal of the Movement Disorder Society. 1: 119-27. PMID 2904116 DOI: 10.1002/mds.870010206  0.84
1985 Burke RE, Fahn S. The effect of selective lesions on vestibular nuclear complex choline acetyltransferase activity in the rat. Brain Research. 360: 172-82. PMID 4075169 DOI: 10.1016/0006-8993(85)91233-8  0.52
1985 Burke RE, Fahn S. Pharmacokinetics of trihexyphenidyl after short-term and long-term administration to dystonic patients. Annals of Neurology. 18: 35-40. PMID 4037749 DOI: 10.1002/ana.410180107  0.52
1985 Burke RE, Fahn S. Serum trihexyphenidyl levels in the treatment of torsion dystonia. Neurology. 35: 1066-9. PMID 4010950 DOI: 10.1212/WNL.35.7.1066  0.52
1985 Burke RE, Reches A, Traub MM, Ilson J, Swash M, Fahn S. Tetrabenazine induces acute dystonic reactions. Annals of Neurology. 17: 200-2. PMID 3977303 DOI: 10.1002/ana.410170217  0.52
1985 Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology. 35: 73-7. PMID 3966004 DOI: 10.1212/WNL.35.1.73  0.52
1985 Burke RE, Fahn S. Choline acetyltransferase activity of the principal vestibular nuclei of rat, studied by micropunch technique. Brain Research. 328: 196-9. PMID 3882194 DOI: 10.1016/0006-8993(85)91344-7  0.52
1985 Reches A, Liu KP, Karpiak SE, Fahn S, Cooper TB, Suckow R, Jackson V, Tamir H. Serotonin depletion induced by reserpine is attenuated by prophylactic administration of lithium. European Journal of Pharmacology. 113: 225-31. PMID 2412842 DOI: 10.1016/0014-2999(85)90739-3  0.36
1984 Stern Y, Mayeux R, Ilson J, Fahn S, Cote L. Pergolide therapy for Parkinson's disease: neurobehavioral changes. Neurology. 34: 201-4. PMID 6538009 DOI: 10.1212/WNL.34.2.201  0.84
1984 Bodnar RJ, Kordower JH, Reches A, Wallace MM, Fahn S. Reductions in pain thresholds and morphine analgesia following intracerebroventricular parachlorophenylalanine. Pharmacology, Biochemistry, and Behavior. 21: 79-84. PMID 6235525 DOI: 10.1016/0091-3057(84)90134-5  0.36
1983 Reches A, Burke RE, Jiang D, Wagner HR, Fahn S. Neurotensin interacts with dopaminergic neurons in rat brain. Peptides. 4: 43-8. PMID 6866808 DOI: 10.1016/0196-9781(83)90163-8  0.52
1983 Ilson J, Fahn S, Mayeux R, Cote LJ, Snider SR. Pergolide treatment in parkinsonism. Advances in Neurology. 37: 85-94. PMID 6858780  0.84
1983 Burke RE, Fahn S. Chlorpromazine methiodide acts at the vestibular nuclear complex to induce barrel rotation in the rat. Brain Research. 288: 273-81. PMID 6661622 DOI: 10.1016/0006-8993(83)90103-8  0.52
1983 Burke RE, Fahn S. Studies of somatostatin-induced barrel rotation in rats. Regulatory Peptides. 7: 207-20. PMID 6141624 DOI: 10.1016/0167-0115(83)90014-9  0.52
1983 Burke RE, Fahn S. Electroencephalographic studies of chlorpromazine methiodide and somatostatin-induced barrel rotation in rats. Experimental Neurology. 79: 704-13. PMID 6130962 DOI: 10.1016/0014-4886(83)90034-1  0.52
1982 Matison R, Mayeux R, Rosen J, Fahn S. "Tip-of-the-tongue" phenomenon in Parkinson disease. Neurology. 32: 567-70. PMID 7200216 DOI: 10.1212/WNL.32.5.567  0.84
1982 Burke RE, Fahn S, Wagner HR, Smeal M. Chlorpromazine methiodide-induced barrel rotation: an antimuscarinic effect. Brain Research. 250: 133-42. PMID 7139312 DOI: 10.1016/0006-8993(82)90959-3  0.52
1982 Mayeux R, Fahn S. Paroxysmal dystonic choreoathetosis in a patient with familial ataxia. Neurology. 32: 1184-6. PMID 6889704  0.84
1982 Burke RE, Fahn S, Jankovic J, Marsden CD, Lang AE, Gollomp S, Ilson J. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology. 32: 1335-46. PMID 6128697 DOI: 10.1212/WNL.32.12.1335  0.52
1982 Burke RE, Fahn S, Jankovic J, Marsden CD, Lang AE, Gollomp S, Ilson J. Tardive dystonia and inappropriate use of neuroleptic drugs. Lancet. 1: 1299. PMID 6123031 DOI: 10.1016/S0140-6736(82)92856-2  0.52
1981 Burke RE, Fahn S, Mayeux R, Weinberg H, Louis K, Willner JH. Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease. Neurology. 31: 1022-5. PMID 6115336  0.84
1980 Mayeux R, Hunter S, Fahn S. More on myoclonus in Alzheimer disease. Annals of Neurology. 8: 200. PMID 7425576 DOI: 10.1002/ana.410080214  0.84
1980 Burke RE, Fahn S, Gold AP. Delayed-onset dystonia in patients with "static" encephalopathy. Journal of Neurology, Neurosurgery, and Psychiatry. 43: 789-97. PMID 7191439 DOI: 10.1136/jnnp.43.9.789  0.84
1980 Fahn S, Mayeux R. Unilateral Parkinson's disease and contralateral tardive dyskinesia: a unique case with successful therapy that may explain the pathophysiology of these two disorders. Journal of Neural Transmission. Supplementum. 179-85. PMID 6933220  0.84
1979 Lesser RP, Fahn S, Snider SR, Cote LJ, Isgreen WP, Barrett RE. Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology. 29: 1253-60. PMID 573405 DOI: 10.1212/WNL.29.9_Part_1.1253  0.84
1979 Fahn S, Cote LJ, Snider SR, Barrett RE, Isgreen WP. The role of bromocriptine in the treatment of parkinsonism. Neurology. 29: 1077-83. PMID 572493 DOI: 10.1212/WNL.29.8.1077  0.84
1978 Mayeux R, Fahn S. Strokes and ulcerative colitis. Neurology. 28: 571-4. PMID 565888  0.84
1976 Snider SR, Fahn S, Isgreen WP, Cote LJ. Primary sensory symptoms in parkinsonism. Neurology. 26: 423-9. PMID 944393 DOI: 10.1212/WNL.26.5.423  0.84
1976 Fahn S, Côté LJ. Stability of enzymes in post-mortem rat brain. Journal of Neurochemistry. 26: 1039-42. PMID 5578 DOI: 10.1111/j.1471-4159.1976.tb06490.x  0.84
1975 Snider SR, Fahn S, Cote LJ, Isgreen WP. Letter: Pain, paresthesia and parkinsonism. The New England Journal of Medicine. 293: 200. PMID 1134539 DOI: 10.1056/nejm197507242930418  0.4
1974 Earnest MP, Fahn S, Karp JH, Rowland LP. Normal pressure hydrocephalus and hypertensive cerebrovascular disease. Archives of Neurology. 31: 262-6. PMID 4414845  0.84
1964 ROWLAND LP, FAHN S, HIRSCHBERG E, HARTER DH. MYOGLOBINURIA. Archives of Neurology. 10: 537-62. PMID 14130414  0.84
1963 FAHN S, SCHOTLAND DL, ROWLAND LP. MCARDLE'S DISEASE: HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE. Transactions of the American Neurological Association. 88: 145-7. PMID 14272202  0.84
1963 ROWLAND LP, FAHN S, SCHOTLAND DL. MCARDLE'S DISEASE. HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE. Archives of Neurology. 9: 325-42. PMID 14055781 DOI: 10.1001/archneur.1963.00460100013001  0.84
Show low-probability matches.